Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Intimation Of The Grant Of Options Under Genesys ESOP Scheme, 2020

 We would like to inform you that the Compensation Committee of the Board of Directors of the Company at its meeting held on Thursday, i.e April 14, 2022 considered and approved re-grant of 27,500 Stock Options out of the lapsed Options to its eligible employees under the Company's ESOP Scheme- 2020. One Stock Option grant represents one equity share of Rs. 5/- each of the Company. The above Options were granted at an exercise price of Rs. 200/- per equity share, which is at 66.66% discount to the closing price of Rs. 600.10 of the company's equity share on the National Stock Exchange of India on April 13, 2022.
15-04-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vineet ChopraDesignation :- Company Secretary and Compliance Officer
13-04-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sundar Iyer & PACs
31-03-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Retirement

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Ratan Das - Chief Financial Officer and Key Managerial Personnel of the Company has retired on 31st March 2022 at the end of closure of business hours upon his attaining the age of superannuation. Further, the details/disclosures required under Regulation 30 of the SEBI Listing Regulations, read with Schedule III thereto and the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 ('SEBI Circular'), is enclosed herewith as Annexure. Please take the above on your records
31-03-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Closure of Trading Window

 This is to inform you that as per the Company's Code of Conduct framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate relatives from April 01, 2022 till the expiry of 48 hours after the declaration of financial results of the Company for the quarter and financial year ended March 31, 2022. We request you to take the same on your record.
31-03-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 This is to inform you that the Compensation Committee at its meeting held on February 17, 2022 approved allotment of 57,805 equity shares of face value of Rs. 5.00 each to the eligible employees pursuant to the exercise of the Stock Options under the Genesys ESOP Scheme - 2020. Consequently, post-allotment, the paid-up share capital of the Company shall stand increased to Rs. 15,68,13,760/- divided into 3,13,62,752 equity shares of face value of Rs. 5.00 each. These equity shares shall rank pari passu with the existing equity shares of the Company in all respects. You are requested to take the above on your record.
18-02-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed a copy of newspaper publication of un-audited standalone and consolidated financial results of the Company for the third quarter and nine months ended December 31, 2021 as published in the newspapers - The Free Press Journal (English) and Navshakti (Marathi) Request you to take the same on records
16-02-2022

Genesys Int Standalone December 2021 Net Sales at Rs 39.03 crore, up 68.3% Y-o-Y

 NULL
16-02-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1)Of SEBI (LODR) Regulations, 2015 For The Quarter And Nine Months Ended December 31, 2021

 In compliance with the Regulation 32(1) of SEBI [Listing obligations and Disclosure Requirements) Regulations, 2015 please find attached the Statement of Deviation or variation or Utilization of funds raised through Preferential Issue by the company for the quarter and nine months ended December 31, 2021 as reviewed by the Audit committee. You are requested to take the above on your records.
14-02-2022
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 14, 2022

 In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, February 14, 2022 has inter alia considered and approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021. Copies of the following are enclosed: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021. ii. Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of Board commenced at 2.00 p.m. and concluded at 3.45 p.m. Kindly take the above information on your record.
14-02-2022
Next Page
Close

Let's Open Free Demat Account